John C. Flickinger

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity”.

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001046

N/A

0.970DataRank · unranked

38 citations

Jagmohan Singh, Robert D. Carlson, Elinor Leong, Trevor R. Baybutt, Joshua R. Barton +9 more

GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer

Expert Review of Precision Medicine and Drug Development(2021)10.1080/23808993.2021.1876518

N/A

0.434DataRank · unranked

17 citations

John C. Flickinger, Babar Bashir, Megan Weindorfer, Sanjna Shelukar, Madison Crutcher +3 more

Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy

npj Vaccines(2022)10.1038/s41541-022-00483-z

N/A

0DataRank · unranked

16 citations

Ross E. Staudt, Jagmohan Singh, Robert D. Carlson, Joshua R. Barton, Trevor R. Baybutt +6 more

T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C

Frontiers in Immunology(2022)10.3389/fimmu.2022.855759

N/A

0DataRank · unranked

18 citations

Jagmohan Singh, Yanki Yarman, Robert D. Carlson, Joshua R. Barton, Scott A. Waldman +2 more